Recombinant Human NR3C2 Protein，GST

NR3C2, also known as the mineralocorticoid receptor (MR), is a steroid hormone receptor that plays a crucial role in regulating electrolyte balance, blood pressure, and cardiovascular function. Research on NR3C2 has gained significant attention due to its involvement in various physiological and pathophysiological processes, including hypertension, heart failure, and metabolic disorders. The receptor is activated by mineralocorticoids, primarily aldosterone, which exert their effects on gene expression and cellular signaling. Given its critical role in the renin-angiotensin-aldosterone system (RAAS), NR3C2 has become a focal point for understanding the molecular mechanisms underlying cardiovascular diseases. Recombinant NR3C2 proteins have been developed to facilitate studies on its structure, function, and interactions with ligands and other cellular partners. These recombinant proteins enable researchers to dissect the complex signaling pathways mediated by NR3C2 and to explore potential therapeutic targets for conditions associated with dysregulated NR3C2 activity. Additionally, laboratory studies utilizing NR3C2 reconstitution systems are essential for drug development aimed at modulating mineralocorticoid signaling, which could lead to innovative treatments for hypertension and related disorders. Overall, the study of NR3C2 recombinant proteins is a promising avenue for advancing our understanding of the receptor's role in health and disease, paving the way for the development of targeted therapies that could improve patient outcomes in various cardiovascular conditions.